Arca Biopharma | ABIO - Dochód Netto





Dochód Netto Zmiana Data
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Amgen USD 1.82B 486M 2026-03
Arca Biopharma USD -29.58M 694K 2025-12
Biogen USD 319.5M 368.4M 2026-03
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 5.55B 1.21B 2026-03
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD 56.84M 63.82M 2025-12
CSL USD 401M 96.5M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Grifols EUR 114.37M 34.03M 2025-12
Laboratory Of America USD 277.8M 113.1M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
Otsuka Holdings JPY 98.35B 32.86B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03